Stratec SE (SBS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Stratec SE (SBS) has a cash flow conversion efficiency ratio of 0.091x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€21.49 Million ≈ $25.13 Million USD) by net assets (€236.79 Million ≈ $276.84 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Stratec SE market cap and net worth for the company's overall valuation and market capitalisation.
Stratec SE - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how Stratec SE's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Stratec SE Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Stratec SE ranked by their cash flow conversion efficiency. Explore SBS cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Crescendo Corporation Bhd
KLSE:6718
|
0.026x |
|
Shanghai Sanmao Enterprise Group Co Ltd A
SHG:600689
|
-0.024x |
|
Beacon Minerals Limited
AU:BCN
|
0.362x |
|
Lightbridge Corporation
F:N7ON
|
-0.022x |
|
MFS Intermediate Income Trust
NYSE:MIN
|
0.047x |
|
Wistron Information Technology & Services
TWO:4953
|
-0.126x |
|
Provident Agro Tbk
JK:PALM
|
0.279x |
|
Corby Spirit and Wine Limited
TO:CSW-A
|
-0.088x |
Annual Cash Flow Conversion Efficiency for Stratec SE (2002–2025)
The table below shows the annual cash flow conversion efficiency of Stratec SE from 2002 to 2025. View SBS live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €237.32 Million ≈ $277.45 Million |
€-433.00K ≈ $-506.22K |
-0.002x | -100.91% |
| 2024-12-31 | €242.53 Million ≈ $283.55 Million |
€48.71 Million ≈ $56.95 Million |
0.201x | +141.25% |
| 2023-12-31 | €233.33 Million ≈ $272.78 Million |
€19.43 Million ≈ $22.71 Million |
0.083x | +82.38% |
| 2022-12-31 | €225.18 Million ≈ $263.26 Million |
€10.28 Million ≈ $12.02 Million |
0.046x | -85.20% |
| 2021-12-31 | €205.76 Million ≈ $240.55 Million |
€63.47 Million ≈ $74.21 Million |
0.308x | +67.12% |
| 2020-12-31 | €172.54 Million ≈ $201.72 Million |
€31.85 Million ≈ $37.23 Million |
0.185x | +38.04% |
| 2019-12-31 | €159.01 Million ≈ $185.90 Million |
€21.26 Million ≈ $24.86 Million |
0.134x | +70.31% |
| 2018-12-31 | €152.20 Million ≈ $177.94 Million |
€11.95 Million ≈ $13.97 Million |
0.079x | -58.67% |
| 2017-12-31 | €157.84 Million ≈ $184.53 Million |
€29.98 Million ≈ $35.05 Million |
0.190x | +67.93% |
| 2016-12-31 | €143.72 Million ≈ $168.02 Million |
€16.26 Million ≈ $19.00 Million |
0.113x | -43.40% |
| 2015-12-31 | €130.28 Million ≈ $152.31 Million |
€26.03 Million ≈ $30.44 Million |
0.200x | -43.67% |
| 2014-12-31 | €112.05 Million ≈ $131.00 Million |
€39.75 Million ≈ $46.47 Million |
0.355x | +44.63% |
| 2013-12-31 | €97.18 Million ≈ $113.61 Million |
€23.84 Million ≈ $27.87 Million |
0.245x | +729.52% |
| 2012-12-31 | €91.98 Million ≈ $107.54 Million |
€2.72 Million ≈ $3.18 Million |
0.030x | -77.01% |
| 2011-12-31 | €83.23 Million ≈ $97.31 Million |
€10.71 Million ≈ $12.52 Million |
0.129x | +538.58% |
| 2010-12-31 | €71.88 Million ≈ $84.03 Million |
€1.45 Million ≈ $1.69 Million |
0.020x | -89.02% |
| 2009-12-31 | €59.29 Million ≈ $69.31 Million |
€10.88 Million ≈ $12.72 Million |
0.183x | +95.22% |
| 2008-12-31 | €49.90 Million ≈ $58.34 Million |
€4.69 Million ≈ $5.48 Million |
0.094x | -52.28% |
| 2007-12-31 | €48.58 Million ≈ $56.79 Million |
€9.57 Million ≈ $11.19 Million |
0.197x | -10.44% |
| 2006-12-31 | €40.13 Million ≈ $46.92 Million |
€8.83 Million ≈ $10.32 Million |
0.220x | +430.06% |
| 2005-12-31 | €31.52 Million ≈ $36.85 Million |
€1.31 Million ≈ $1.53 Million |
0.041x | -73.32% |
| 2004-12-31 | €15.47 Million ≈ $18.08 Million |
€2.41 Million ≈ $2.81 Million |
0.156x | +384.79% |
| 2003-12-31 | €12.87 Million ≈ $15.05 Million |
€413.00K ≈ $482.84K |
0.032x | -99.98% |
| 2002-12-31 | €11.17K ≈ $13.06K |
€1.73 Million ≈ $2.03 Million |
155.162x | -- |
About Stratec SE
Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and instrumentation and softwar… Read more